Optimi Health Corp. (OPTH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−5.0x

Market Cap

$27.34M

MomentumView details →

1D Return

+1.60%

YTD Return

−30.36%

RSI (14)

47.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−5.0x

Market Cap

$27.34M

RSI (14)

47.0

MomentumView details →

1D Return

+1.60%

YTD Return

−30.36%

ProfitabilityView details →

Gross Margin

−699.11%

Net Margin

−4611.03%

EBITDA Margin

−3249.95%

ROE (TTM)

−49.82%

ROA (TTM)

−33.98%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+74.23%

EPS CAGR 3Y

+42.57%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$0.40

EPS Surprise

−53.85%

Beats (12Q)

0/12

Next Q EPS Est

−$0.13

Avg Surprise (4Q)

−26.92%

Rev Surprise

−36.27%

Capital & dividendView details →

Debt/Equity

0.29x

Current Ratio

1.73x

Quick Ratio

1.69x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

134171.00

Net Income (TTM)

−6.19M

Op. CF (TTM)

−4.36M

Next earningsFeb 2, 2027 →

Latest newsMore news →

Optimi Health shipped its third commercial psilocybin export to Australia.60d ago

Optimi Health completed the export of its 5mg psilocybin capsules to Australia for patients with treatment-resistant depression, marking its third commercial shipment since launching the product in September 2025.67d ago

Similar companies

Bioceres Crop Solutions Corp.BIOX BioHarvest Sciences Inc. Common StockBHST Lavoro LimitedLVRO Origin Agritech LimitedSEED American Vanguard CorporationAVD Agroz Inc. Ordinary SharesAGRZ Find similar companies →

Latest newsMore news →

Optimi Health shipped its third commercial psilocybin export to Australia.60d ago Optimi Health completed the export of its 5mg psilocybin capsules to Australia for patients with treatment-resistant depression, marking its third commercial shipment since launching the product in September 2025.67d ago Optimi Health Corp. launched two standardized microdose psilocybin finished drug products (1mg and 2mg) for clinical research.80d ago